ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,786.20
-1.32%
S&P ASX All Technology
3,450.50
-1.11%
Brent Oil
70.30
0.84%
US Dollar vs AUD
1.59025
0.10%
Bitcoin
82,531.27
-0.38%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Schrodinger Inc (SDGR) Share Price

Schrodinger Inc

Schrodinger Inc (SDGR)

NASDAQ
21.765
0.105
( 0.48% )
Updated: 01:04:27
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
21.765
Bid
21.72
Offer
21.82
Volume
79,954
21.63 Day's Range 22.37
16.67 52 Week Range 29.15
Market Cap
1.59B
Previous Close
21.66
Open
22.26
Last Trade
2
@
21.76
Last Trade Time
01:04:29
Financial Volume
US$ 1,768,558
VWAP
22.1197
Average Volume (3m)
926,554
Shares Outstanding
73,038,393
Dividend Yield
-
PE Ratio
-8.63
Earnings Per Share (EPS)
-2.56
Revenue
207.54M
Net Profit
-187.12M

About Schrodinger Inc

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the... Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. Schrodinger generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.schrodinger.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Schrodinger Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SDGR. The last closing price for Schrodinger was US$21.66. Over the last year, Schrodinger shares have traded in a share price range of US$ 16.67 to US$ 29.15.

Schrodinger currently has 73,038,393 shares in issue. The market capitalisation of Schrodinger is US$1.58 billion. Schrodinger has a price to earnings ratio (PE ratio) of -8.63.

Ask ADVFN Intelligence (AI)

SDGR Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
11 March 2025
SDGR (0.48%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
11 March 2025
SDGR (0.48%)

Form 8-K - Current report
Edgar (US Regulatory)
10 March 2025
SDGR (0.48%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
08 March 2025
SDGR (0.48%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 March 2025
SDGR (0.48%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 March 2025
SDGR (0.48%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 March 2025
SDGR (0.48%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 March 2025
SDGR (0.48%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 March 2025
SDGR (0.48%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 March 2025
SDGR (0.48%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.5652.6650943396221.222.3719.4894767621.03713987CS
4-2.125-8.894935119323.8928.4719.48111917122.72742367CS
120.6653.1516587677721.128.4718.292655422.65676366CS
261.1755.706653715420.5928.4716.6779130021.19134815CS
52-4.735-17.867924528326.529.1516.6774618021.88317681CS
156-6.435-22.819148936228.259.2415.8578248328.33341903CS
260-16.725-43.452844894838.4911715.8585200143.33419232CS

SDGR - Frequently Asked Questions (FAQ)

What is the current Schrodinger share price?
The current share price of Schrodinger is US$ 21.765
How many Schrodinger shares are in issue?
Schrodinger has 73,038,393 shares in issue
What is the market cap of Schrodinger?
The market capitalisation of Schrodinger is USD 1.58B
What is the 1 year trading range for Schrodinger share price?
Schrodinger has traded in the range of US$ 16.67 to US$ 29.15 during the past year
What is the PE ratio of Schrodinger?
The price to earnings ratio of Schrodinger is -8.63
What is the cash to sales ratio of Schrodinger?
The cash to sales ratio of Schrodinger is 7.78
What is the reporting currency for Schrodinger?
Schrodinger reports financial results in USD
What is the latest annual turnover for Schrodinger?
The latest annual turnover of Schrodinger is USD 207.54M
What is the latest annual profit for Schrodinger?
The latest annual profit of Schrodinger is USD -187.12M
What is the registered address of Schrodinger?
The registered address for Schrodinger is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Schrodinger website address?
The website address for Schrodinger is www.schrodinger.com
Which industry sector does Schrodinger operate in?
Schrodinger operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
STISolidion Technology Inc
US$ 0.222699
(76.61%)
303.6M
VSTEVast Renewable Ltd
US$ 0.7451
(49.05%)
132.06M
OPRXOptimizeRx Corporation
US$ 6.14
(48.31%)
5.59M
SNCRSynchronoss Technologies Inc
US$ 10.04
(40.81%)
98.1k
GRPNGroupon Inc
US$ 12.90
(32.04%)
2.36M
ZYXIZynex Inc
US$ 4.005
(-42.79%)
318.58k
HEPAHepion Pharmaceuticals Inc
US$ 0.05
(-40.48%)
25.33M
IRBTiRobot Corporation
US$ 3.94
(-37.56%)
4.63M
APDNApplied DNA Sciences Inc
US$ 0.0949
(-35.44%)
6.62M
SYRSSyros Pharmaceuticals Inc
US$ 0.088
(-35.29%)
9.78M
STISolidion Technology Inc
US$ 0.222699
(76.61%)
303.6M
VSTEVast Renewable Ltd
US$ 0.7451
(49.05%)
132.06M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9.005
(13.84%)
81.2M
NVDANVIDIA Corporation
US$ 115.49
(6.19%)
65.13M
AREBAmerican Rebel Holdings Inc
US$ 0.328
(7.93%)
43.42M

SDGR Discussion

View Posts
411OTCshare 411OTCshare 4 weeks ago
Is this still a viable, long term investment? No one has posted for a while.
👍️0
jsc52033 jsc52033 4 months ago
If Biill Gates thinks its got potential it a risk I can take
👍️0
lambchops lambchops 5 months ago
Yep, it just seems like SDGR isn't getting much love. But nothing has changed as they move towards their goals. I look at it as aa time to continue to accumulate shares. One of these days SDGR will see a big jump.

Look at CERS.

All the best! stay in contact.

LC

SDGR
👍️0
north40000 north40000 5 months ago
Not much to say, currently. SDGR shares have been in a rather steady decline since I purchased a few in May 2023. I am curious where/how the company is aiding discovery of new molecules for potential use in healthcare sector, cf. the recent Nobel Prize awards. Is this turnaround time? How proficient has the company been in its AI-aided experiments?

I have concentrated more on NVDA, IONQ, JNJ, PFE, MRK, GILD, HALO, CPRX, VCEL, WGS whose market valuations seem headed higher in our portfolios.
👍️0
lambchops lambchops 8 months ago
Anybody interested on posting on this one?

LC

👍️0
scotsand scotsand 1 year ago
This needs to turn around soon. So oversold.
👍️0
scotsand scotsand 2 years ago
Beast mode
👍️0
scotsand scotsand 2 years ago
Love this ticker
👍️0
scotsand scotsand 2 years ago
Up 20%. Guess was right… adding.
👍️0
scotsand scotsand 2 years ago
Now is the time to add.
👍️0
Porterhouse10 Porterhouse10 3 years ago
Cathy Woods adding
👍️0
nowwhat2 nowwhat2 4 years ago



👍️0
adtime adtime 4 years ago
This was a fun move hope someone followed ;) 8% at peak today ftw
👍️0
adtime adtime 4 years ago
Nice set up if gets into 60
👍️0
ernie44 ernie44 4 years ago
M and A -------------------------
merger looming---microsoft
👍️0
Bucketh3ad Bucketh3ad 5 years ago
Smh
👍️0
chrispy2468 chrispy2468 5 years ago
Any insight to this upward move after hours?
👍️0
canadiansalmongal canadiansalmongal 5 years ago
Very Solid company with HUGE money supporting it...Long term Hold this is a golden ticket going forward $100 PT this time next year!
👍️0
chrispy2468 chrispy2468 5 years ago
Little action AH
👍️0
RodgeDodger RodgeDodger 5 years ago
Still running
👍️0
crudeoil24 crudeoil24 5 years ago
I am not holding shares. It may run some more, plus not everyone is familiar with Citron the beast! > LOL.
👍️0
realfast95 realfast95 5 years ago
yea he exaggerates his long ideas. TLRY,RVLV come to mind
👍️0
crudeoil24 crudeoil24 5 years ago
Citron > will they be shorting tomorrow? Playing off the TSLA hype!

👍️0
chrispy2468 chrispy2468 5 years ago
Bullish
👍️0
TheFinalCD TheFinalCD 5 years ago
https://citronresearch.com/schrodinger-sdgr-taking-drug-discovery-to-the-space-age/
👍️0
realfast95 realfast95 5 years ago
Citron pump

https://twitter.com/CitronResearch/status/1230538195726503942

Citron Research
@CitronResearch
$SDGR the most important IPO past 5 years. Taking drug discovery to "space age". The parallels to an early stage $TSLA are too obvious to ignore. Don't take Citron's word, look at the majority shareholders AI molecular simulation is real disruption. TGT- $80

👍️0
RodgeDodger RodgeDodger 5 years ago
Still running
👍️0
crudeoil24 crudeoil24 5 years ago
Schrodinger Shares Surge 55% After IPO Priced Above High End of Range >SDGR
12:39 pm ET February 6, 2020 (Dow Jones) Print
By Colin Kellaher

Shares of Schrodinger Inc. (SDGR) jumped more than 55% in their trading debut Thursday after the drug discovery software company's upsized initial public offering of 11.9 million shares was priced at $17 apiece, above the expected range.

Schrodinger shares recently were trading at $26.54, up about 56%, after opening at $26.

The New York company, whose investors include D.E. Shaw and the Bill & Melinda Gates Foundation, previously said it planned to sell 10 million shares at $14 to $16 each in the IPO.

The company has granted the underwriters an option to buy up to 1.78 million additional shares.
👍️0
crudeoil24 crudeoil24 5 years ago
Schrodinger Inc is headquartered in New York City, New York, United States and is a software publisher. The company's key areas of interest are Computational Chemistry Software, Molecular Modeling, Dockings, Homology Modeling, Cheminformatics, Pharmacophore Modeling, Qsars, Computational Biology, Computer Chemistry, Quantum Chemistry, Software For Chemistry. The company was founded in 1995.

👍️0

Your Recent History

NASDAQ
SDGR
Schrodinger
BIT
F35805
Vontobel Financial Produ...
BIT
SMSWLD
ETF
TG
CEC
Ceconomy
BIT
P1U6B2
BNP Paribas Issuance
NASDAQ
CTBI
Community Trust Bancorp
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads